0.326 USD
-0.01 (-3.15%)
0.323 USD
0 (-0.92%)
Overall RVPH gets a fundamental rating of 1 out of 10. We evaluated RVPH against 190 industry peers in the Pharmaceuticals industry. While RVPH seems to be doing ok healthwise, there are quite some concerns on its profitability. RVPH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year RVPH has reported negative net income.
- In the past year RVPH has reported a negative cash flow from operations.
- RVPH had negative earnings in 4 of the past 5 years.
- RVPH had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- RVPH's Return On Assets of -158.77% is on the low side compared to the rest of the industry. RVPH is outperformed by 86.91% of its industry peers.
- RVPH has a Return On Equity of -500.18%. This is amonst the worse of the industry: RVPH underperforms 80.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -158.77% | ||
| ROE | -500.18% | ||
| ROIC | N/A |
ROA(3y)-169.33%
ROA(5y)-106.82%
ROE(3y)-1567.74%
ROE(5y)-946.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for RVPH so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for RVPH has been increased compared to 1 year ago.
- Compared to 5 years ago, RVPH has more shares outstanding
- The debt/assets ratio for RVPH is higher compared to a year ago.
2.2 Solvency
- RVPH has an Altman-Z score of -20.32. This is a bad value and indicates that RVPH is not financially healthy and even has some risk of bankruptcy.
- RVPH's Altman-Z score of -20.32 is on the low side compared to the rest of the industry. RVPH is outperformed by 84.29% of its industry peers.
- RVPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -20.32 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 1.39 indicates that RVPH should not have too much problems paying its short term obligations.
- The Current ratio of RVPH (1.39) is worse than 73.30% of its industry peers.
- A Quick Ratio of 1.39 indicates that RVPH should not have too much problems paying its short term obligations.
- The Quick ratio of RVPH (1.39) is worse than 66.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.39 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 58.56% over the past year.
EPS 1Y (TTM)58.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- RVPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.15% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y54.98%
EPS Next 2Y29.54%
EPS Next 3Y18.76%
EPS Next 5Y14.15%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for RVPH. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RVPH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as RVPH's earnings are expected to grow with 18.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.54%
EPS Next 3Y18.76%
5. Dividend
5.1 Amount
- No dividends for RVPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
REVIVA PHARMACEUTICALS HOLDI / RVPH FAQ
Can you provide the ChartMill fundamental rating for REVIVA PHARMACEUTICALS HOLDI?
ChartMill assigns a fundamental rating of 1 / 10 to RVPH.
What is the valuation status of REVIVA PHARMACEUTICALS HOLDI (RVPH) stock?
ChartMill assigns a valuation rating of 0 / 10 to REVIVA PHARMACEUTICALS HOLDI (RVPH). This can be considered as Overvalued.
What is the profitability of RVPH stock?
REVIVA PHARMACEUTICALS HOLDI (RVPH) has a profitability rating of 0 / 10.